Effects of candesartan on the renin system in conscious rats

Journal of the American Society of Nephrology

Volumn 10, Issue 1 SUPPL. 11, 1999, Pages

  Wagner, Charlotte ^a   Kurtz, Armin ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; CANDESARTAN HEXETIL; LOSARTAN; RENIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HORMONAL REGULATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032905569     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Kurtz A, Wagner C: Regulation of renin secretion by angiotensin II-AT1 receptors. J Am Soc Nephrol Suppl 10: S162-S168, 1999
2. Llorens-Cortes C, Greenberg B, Huang H, Corvol P: Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24: 538-548, 1994
3. 1B receptor gene expression in rat adrenals. Pflügers Arch 436: 323-328, 1998
4. Iwai N, Inagami T: Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun 182: 1094-1099, 1992
5. Kitami Y, Takafumi O, Marumoto K, Wakamiya R, Hiwada K: Differential gene expression and regulation of type-1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 188: 446-452, 1992
6. Shibata H, Suzuki H, Maruyama T, Murata K, Saruta T: Effect of dietary chloride on aldosterone synthase induction and angiotensin II receptors in rat adrenals. Mol Cell Endocrinol 114: 167-175, 1995
7. Schricker K, Hegyi I, Hamann M, Kaissling B, Kurtz A: Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II. Proc Natl Acad Sci USA 92: 8006-8010, 1995
8. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 62: 156-159, 1987
9. Mizuno K, Niimura S, Katoh K, Fukuchi S: TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue reninangiotensin system in spontaneously hypertensive rats. Life Sci 54: 1987-1994, 1994
10. Kawabata M, Takabatake T, Ohta H, Nakamura S, Hara H, Ohta K, Takakuwa H, Han WH, Kobayashi K: Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension. Blood Press 5: S117-S121, 1994
11. Delacretaz E, Nussberger J, Biollaz J, Waeber B, Brunner HR: Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. Hypertension 25: 14-21, 1995
12. Wada T, Sanada T, Ojima M, Kanagawa R, Nishikawa K, Inada Y: Combined effects of the angiotensin II antagonist candesartan cilexitil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats. Hypertens Res 19: 247-254, 1996
13. Haddad G, Amiri F, Garcia R: Modulation of renal glomerular angiotensin II receptors by ACE inhibition and AT1 receptor antagonism. Regul Pept 68: 111-117, 1997
14. Hubner R, Hogemann AM, Sunzel M, Riddell JG: Pharmacokinetics of candesartan after single and repeated doses of candesartan cilexitil in young and elderly healthy volunteers. J Hum Hypertens 11: S19-S25, 1997